Emily Durden

Emily Durden, PhD, is a health outcomes researcher with extensive expertise in real-world evidence (RWE) research and a strong focus on market access initiatives. Currently serving as the Director of Research Strategy at Bayer, Emily has held multiple leadership roles, including Director of Health Economics and Outcomes Research at both Headspace Inc. and Woebot Health. Emily has contributed to over 35 publications in peer-reviewed journals and delivered numerous presentations at conferences. With a robust academic background, Emily holds a PhD and an MA in Sociology from The University of Texas at Austin, as well as dual bachelor's degrees in Psychology and Criminology from the University of Florida.